Is buscogast not allowed to take while doing h pylori stool antigen test
Reading File
Searching the Web
H pylori stool antigen test medications to avoid buscopan hyoscine butylbromide interference
Searching PubMed
H pylori stool antigen test accuracy medication interference
Buscogast (hyoscine butylbromide / Buscopan) does NOT need to be stopped before an H. pylori stool antigen test. Here is a clear breakdown:
Drugs That CAN Interfere (cause false negatives)
These suppress H. pylori activity and can make the test come back negative even when the bacteria is present:
| Drug Class | Examples | How long to stop before testing |
|---|---|---|
| Antibiotics | Amoxicillin, clarithromycin, metronidazole, any antibiotic | 4 weeks before |
| Proton pump inhibitors (PPIs) | Omeprazole, pantoprazole, esomeprazole, lansoprazole | 2 weeks before (minimum 1 week) |
| Bismuth compounds | Pepto-Bismol, De-Nol | 4 weeks before |
These three drug classes directly inhibit H. pylori or drastically lower its antigen shedding into stool, leading to false-negative results.
Drugs That Do NOT Interfere
These do not need to be stopped:
- Antispasmodics / anticholinergics - including Buscogast (hyoscine butylbromide) - have no bacteriostatic or bactericidal action and do not affect antigen shedding
- H2 blockers (ranitidine, famotidine) - minor concern, sometimes advised to stop 4-6 hours before, but they do not suppress the bacteria the way PPIs do
- Standard antacids (Mylanta, Gaviscon) - also only a short washout of 4-6 hours at most
Why Buscogast is Fine
Buscogast works by blocking muscarinic receptors to relax smooth muscle. It has no effect on:
- H. pylori bacterial load or viability
- Antigen production or secretion
- Stool transit in a way that would dilute or destroy the antigen
Multiple laboratory guidelines (Sullivan Nicolaides Pathology, TECHLAB, Children's MN Lab) list only PPIs, antibiotics, and bismuth as restricted medications. Antispasmodics are not mentioned.
Bottom line: You can take Buscogast normally and still do the H. pylori stool antigen test. The medications to worry about are antibiotics (stop 4 weeks prior) and PPIs (stop 2 weeks prior).
Is it ok to take this test 1 week after stopping pantop
Searching the Web
H pylori stool antigen test false negative PPI pantoprazole 1 week washout period accuracy
No, 1 week after stopping pantoprazole is not enough. Here is why:
The Problem With Only 1 Week
PPIs like pantoprazole suppress stomach acid, which in turn reduces H. pylori bacterial density and antigen shedding into stool. Research from a systematic review (cited in UK NHS guidelines) found that:
"When PPIs are started in H. pylori positive patients, SAT and UBT test values fall to negative figures at one week in about 30% of patients, and revert to positive two weeks after stopping treatment."
This means at the 1-week mark after stopping, the bacteria has not fully recovered to detectable levels yet - you are right in the window where a false negative is most likely.
What the Guidelines Say
| Source | Recommendation |
|---|---|
| NICE (UK) guidelines | 2-week washout after PPI before stool antigen test |
| TECHLAB (test manufacturer) | Do not test if PPI taken within 14 days of sample collection |
| Sullivan Nicolaides Pathology | Stop PPIs at least 1 week (preferably 2 weeks) before |
| Children's MN Lab | Repeat test 2 weeks after stopping PPI if negative |
The standard is 2 weeks (14 days). Some labs say a minimum of 1 week is acceptable, but the evidence clearly shows 1 week carries meaningful risk of a false negative - particularly if the test comes back negative, you cannot trust that result.
Practical Advice
- If you test at 1 week and it comes back POSITIVE - that positive result is reliable and accurate. A positive cannot be caused by PPIs.
- If you test at 1 week and it comes back NEGATIVE - you should NOT consider that conclusive. Wait another week and retest.
The safest approach is to simply wait the full 2 weeks from the last dose of pantoprazole before doing the test, so any negative result can be trusted.
He is till having on and off migratory abdominal and chest pain.wht to do.ecg,trop I ,USG abdomen all normal
Asking for Preferences
Finding Sources
Searching the Web
young adult migratory abdominal chest pain sharp stabbing bloating normal ECG troponin ultrasound diagnosis differential
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Good. Now I have enough to give a thorough, clinically useful answer.
Clinical Assessment: On-and-Off Migratory Abdominal + Chest Pain, Young Adult, Normal Workup
The key features here are:
- Young adult
- Sharp/stabbing, migratory - moves between abdomen and chest
- Bloating/flatulence
- Normal ECG, Troponin I, USG abdomen - serious structural/cardiac causes ruled out
This presentation is very consistent with a functional GI disorder, most likely IBS (Irritable Bowel Syndrome) with functional (non-cardiac) chest pain, possibly with an H. pylori component given that's why the stool antigen test was being pursued.
Most Likely Diagnoses (Differential)
1. IBS + Functional Non-Cardiac Chest Pain (Most Likely)
IBS is well-known to produce pain that is not confined to the abdomen - it commonly overlaps with:
- Esophageal chest pain (due to gut hypersensitivity)
- Bloating and flatulence
- Migratory, unpredictable pain locations
Goldman-Cecil Medicine explicitly groups IBS, functional dyspepsia, and esophageal chest pain together as related functional GI disorders. The pain in IBS is visceral hypersensitivity - meaning the gut nerves are oversensitive, and pain can be perceived anywhere along the GI tract from esophagus to colon.
2. Functional Dyspepsia with Esophageal Spasm
Esophageal spasm can cause sharp, stabbing chest pain that radiates to the abdomen and mimics cardiac pain. Normal ECG and troponin effectively rule out ACS.
3. H. pylori Gastritis (pending confirmation)
Given the stool antigen test being done, active H. pylori infection causing gastritis/dyspepsia could contribute to the upper abdominal and chest pain, especially burning or gnawing component.
4. Musculoskeletal / Costochondritis
Sharp, migratory, stabbing pain in young adults can also be musculoskeletal - reproducible by palpation of the chest wall. Worth checking on physical exam.
5. Fibromyalgia (less likely but worth noting)
Swanson's Family Medicine notes that abdominal and chest wall pain, IBS, pelvic pain, and fatigue can co-exist as part of the fibromyalgia spectrum - worth screening if other features are present.
What To Do Next
Immediate Steps
| Investigation | Why |
|---|---|
| CXR (chest X-ray) | Rule out pleural, mediastinal, pulmonary cause of chest pain |
| Complete the H. pylori stool antigen test (wait 2 weeks after stopping pantoprazole) | Active H. pylori could be driving dyspepsia and referred chest pain |
| Physical exam - chest wall palpation | Sharp pain reproducible on pressing = costochondritis/musculoskeletal |
| Esophageal assessment | If esophageal spasm suspected: upper GI endoscopy or barium swallow |
If All Still Normal - Functional GI Workup
Rome IV criteria - assess for:
- IBS: recurrent abdominal pain ≥1 day/week for last 3 months, related to defecation, associated with change in stool frequency/form
- Functional dyspepsia: postprandial fullness, early satiation, epigastric pain/burning
Management (Functional GI / IBS)
| Approach | Details |
|---|---|
| Dietary | Low-FODMAP diet trial - highly effective for bloating and crampy pain in IBS |
| Antispasmodics | Mebeverine or hyoscine (Buscopan) for colicky abdominal pain |
| PPI | For functional dyspepsia/esophageal component - but wait for H. pylori test first |
| Low-dose TCA | Tricyclic antidepressants (e.g. amitriptyline 10-25mg at night) are evidence-based for IBS and non-cardiac chest pain by modulating visceral hypersensitivity - Goldman-Cecil & Yamada's Gastroenterology both support this |
| Psychological support | CBT or gut-directed hypnotherapy - strong evidence in functional GI disorders |
| Reassurance | Explaining the functional nature is itself therapeutic |
Red Flag Symptoms to Watch For
If any of these appear, escalate urgently:
- Unintentional weight loss
- Blood in stool
- Nocturnal pain waking from sleep
- Anemia
- Dysphagia
- Age >45 with new symptoms
Summary
The most practical next steps are:
- CXR to complete the basic workup
- Wait full 2 weeks after stopping pantoprazole, then do the H. pylori stool antigen test
- Chest wall palpation - rule out costochondritis
- Apply Rome IV criteria - diagnose IBS/functional dyspepsia if criteria met
- Start low-FODMAP diet + antispasmodic for symptomatic relief
- Consider low-dose amitriptyline if pain is persistent and affects quality of life
- Upper GI endoscopy if symptoms persist or H. pylori is positive
Should I start pregabalin hs
Finding Sources
Searching PubMed
pregabalin functional abdominal pain IBS visceral hypersensitivity
Searching the Web
pregabalin IBS functional abdominal chest pain evidence 2023 2024
Reading Article
Here is a clear, evidence-based answer:
Pregabalin HS for This Patient - Yes, But With Caveats
Short answer: Pregabalin is a reasonable option, but it is not the first-line choice here. Low-dose amitriptyline HS has stronger evidence and is preferred first. Pregabalin is a valid second-line or add-on.
What the Evidence Says
Pregabalin in Functional GI Pain / IBS
Pregabalin works by binding α2δ subunits of voltage-gated calcium channels in the dorsal horn and gut afferents, reducing visceral hypersensitivity - the core mechanism driving this patient's migratory, functional pain.
Evidence (2022 Systematic Review & Meta-Analysis - PMID 34755926, Neurogastroenterology & Motility):
- Reviewed 13 studies (629 patients) on anti-neuropathic agents in IBS
- Pregabalin was studied in 3 RCTs - generally appeared beneficial for pain outcomes
- Pooled relative risk of 0.50 (95% CI 0.38-0.66) for not improving with anti-neuropathic agents vs. control - meaning these drugs roughly halve the risk of treatment failure
- Amitriptyline was the most extensively studied and had the most consistent evidence
Mayo Clinic RCT (pregabalin vs. placebo in IBS):
- Pregabalin patients showed significant improvement in pain + bloating + diarrhea
- 64% vs 27% achieved >30-point pain score reduction (p=0.042)
Centrally Mediated Abdominal Pain Syndrome (CAPS) RCT (2023):
- Pregabalin 75mg TID showed significantly greater pain reduction than antispasmodic alone
- This patient's migratory, sharp, bloating pain that crosses from abdomen to chest fits CAPS profile
Pregabalin vs. Amitriptyline - Which First?
| Factor | Amitriptyline (preferred first) | Pregabalin |
|---|---|---|
| Evidence in IBS | Strongest (6 RCTs in meta-analysis) | Moderate (3 RCTs) |
| Dose HS | 10-25 mg at night | 75 mg at night |
| Helps with | Pain + sleep + gut motility | Pain + visceral hypersensitivity |
| Side effects | Dry mouth, constipation, sedation | Dizziness, weight gain, sedation |
| Addiction potential | None | Low but exists (GABA-ergic) |
| Cost | Very cheap | More expensive |
| When preferred | IBS-D, pain + poor sleep | IBS-C or amitriptyline not tolerated; pain with anxiety/neuropathic features |
Recommendation for This Patient
Given the profile - young adult, sharp/stabbing migratory pain, bloating, normal investigations:
Step 1 (Start here): Low-dose amitriptyline 10-25 mg HS - best evidence, addresses pain + sleep, cheap, well tolerated at low doses.
Step 2 (If amitriptyline not tolerated or insufficient): Add or switch to pregabalin 75 mg HS - valid choice, especially since this patient also has chest pain with likely visceral hypersensitivity component.
Both together can be used if pain is severe and refractory - they have complementary mechanisms.
One important note: before starting either, complete the H. pylori workup. If H. pylori is confirmed and eradicated, functional symptoms may resolve on their own - making neuromodulators unnecessary.
Amitriptyline wht dose needed
Finding Sources
Searching PubMed
amitriptyline dose IBS irritable bowel syndrome abdominal pain
Reading Article
Reading Article
Excellent - fresh high-quality evidence including the landmark ATLANTIS RCT (2024) and a 2025 meta-analysis across 7 RCTs. Here is the definitive answer:
Amitriptyline Dose for Functional GI Pain (IBS / Functional Abdominal + Chest Pain)
The Dose: Start 10 mg HS → titrate up to 30 mg HS
This is not the antidepressant dose (75-150 mg). At low doses it works purely as a neuromodulator / visceral pain modifier - patients must be told this clearly so they don't refuse it thinking it's for depression.
Evidence-Based Dosing Protocol
Based on the ATLANTIS RCT (2024, PMID 39397570) - the largest and most definitive pragmatic RCT of amitriptyline in IBS (463 patients, 55 GP practices):
| Week | Dose |
|---|---|
| Week 1-2 | 10 mg HS |
| Week 3-4 (if tolerated, symptoms not controlled) | 20 mg HS |
| Week 5+ (if still needed) | 30 mg HS (maximum) |
- Self-titration by the patient was found acceptable and empowering
- Most patients responded at 10-20 mg
- Maximum 30 mg HS for functional GI indications - do not go higher unless treating depression
What the Evidence Shows
| Study | Key Finding |
|---|---|
| ATLANTIS RCT 2024 (n=463) | Amitriptyline significantly better than placebo at 6 months (IBS-SSS score -27 points, p=0.008); 1.78x more likely to get relief (p=0.005) |
| Meta-analysis 2025 (7 RCTs, n=796) | OR 5.30 for treatment response vs placebo (p<0.001); significant reduction in symptom scores; well-tolerated with no significant difference in adverse effects vs placebo |
Practical Tips
- Always give at bedtime (HS) - sedative effect aids sleep, and most side effects (dry mouth, mild drowsiness) wear off by morning
- Warn the patient: "This is a low dose for pain nerves in the gut - not for depression"
- Give it 4-6 weeks at adequate dose before judging effect
- Common side effects at low dose: mild dry mouth, constipation (use with caution if IBS-C subtype), mild morning drowsiness initially (usually resolves in 1-2 weeks)
- Avoid if: urinary retention, glaucoma, prolonged QTc, cardiac arrhythmia, elderly patient (falls risk)
- No need for ECG at these low doses in a young adult with normal cardiac workup
Summary for This Patient
Amitriptyline 10 mg HS for 2 weeks → increase to 20 mg HS if pain not controlled → maximum 30 mg HS
Reassess at 6 weeks. If H. pylori comes back positive and is eradicated, symptoms may resolve and amitriptyline can be tapered off after 3 months.
Budecort 0.5 plus levosalb 0.3 + 3 ml ns for nebulization of 7.8 kg child
Reading File
Finding Sources
Finding Sources
Finding Sources
Searching the Web
budecort 0.5 budesonide levosalbutamol nebulization dose pediatric child kg
Good data. Now let me calculate and verify both drugs for this 7.8 kg child.
Nebulization Check for 7.8 kg Child
Drug 1: Budecort 0.5 (Budesonide 0.5 mg/2 mL)
Dose given: 0.5 mg
| Parameter | Details |
|---|---|
| Standard pediatric dose | 0.25-1 mg twice daily (children 3 months to 12 years, initiation) |
| Maintenance dose | 0.25-0.5 mg twice daily |
| Weight-based? | No - budesonide nebulization is a flat dose, not mg/kg |
| 0.5 mg for 7.8 kg | Appropriate - this is the standard initiation/moderate dose for a child this age/weight |
0.5 mg is correct. It falls within the recommended range for initiation of therapy or moderate persistent asthma in this age group.
Drug 2: Levosalbutamol (Levalbuterol) 0.3 mg
Levosalbutamol is the R-enantiomer of salbutamol. Standard nebulized dose:
| Weight | Dose |
|---|---|
| <20 kg | 0.31 mg (=1.25 mg salbutamol equivalent) nebulized q6-8h |
| >20 kg | 0.63 mg q6-8h |
Dose calculation for 7.8 kg:
- Weight-based: 0.075 mg/kg → 7.8 × 0.075 = ~0.585 mg salbutamol = ~0.3 mg levosalbutamol (R-enantiomer is twice as potent, so 0.3 mg levo = ~0.6 mg salbutamol)
- Standard flat dose for <20 kg: 0.31 mg (unit dose vial)
0.3 mg for 7.8 kg is appropriate - within standard dosing range for a child under 20 kg.
Drug 3: Normal Saline 3 mL
Standard diluent volume for pediatric nebulization is 3-4 mL total. Since Budecort 0.5 already comes in 2 mL, adding 3 mL NS gives total volume ~5 mL (2 mL Budecort + levosalb solution volume + 3 mL NS).
This is acceptable - slightly on the higher volume side but works fine in a standard jet nebulizer. A smaller 2 mL NS would also be fine if desired.
Note: Budesonide respules can be mixed with NS and with salbutamol/levosalbutamol solutions - this is confirmed in the manufacturer's SmPC.
Summary Verdict
| Component | Dose | Status |
|---|---|---|
| Budecort 0.5 (budesonide) | 0.5 mg | Appropriate |
| Levosalbutamol | 0.3 mg | Appropriate for <20 kg child |
| Normal saline | 3 mL | Acceptable diluent |
| Mixing compatibility | All three together | Compatible |
This is a standard, safe nebulization prescription for a 7.8 kg child. Frequency would typically be:
- Acute wheeze/bronchospasm: levosalbutamol q4-6h, budesonide BD (twice daily)
- Maintenance asthma: budesonide BD, levosalbutamol as needed (not routinely with every budesonide dose)
When can I give ebast dc
Finding Sources
Searching the Web
Ebast DC ebastine desloratadine tablet indications dose age children adults
Ebast DC - When to Give It
Ebast DC = Ebastine 10 mg + Desloratadine 5 mg (dual antihistamine combination tablet)
Indications - Give Ebast DC for:
| Condition | Notes |
|---|---|
| Seasonal allergic rhinitis | Sneezing, runny/itchy nose, nasal congestion from pollen/dust |
| Perennial allergic rhinitis | Year-round nasal allergy symptoms |
| Chronic idiopathic urticaria (hives) | Itching, wheals, skin rashes of allergic origin |
| Allergic conjunctivitis | Itchy, watery eyes with allergic rhinitis |
| Post-allergic/urticarial skin reactions | Insect bites, food allergy urticaria |
The combination gives dual H1 blockade from two complementary second-generation antihistamines - useful when a single antihistamine provides insufficient relief.
Age Restriction - IMPORTANT
| Age | Can Give? |
|---|---|
| Adults & children ≥12 years | Yes - standard use |
| Children 6-11 years | Not recommended (ebastine has limited data <12 years) |
| Children <6 years | Do not use (no safety data for ebastine in this group) |
The previous patient you asked about (7.8 kg child) is too young and too small for Ebast DC. This is an adult/adolescent (≥12 years) tablet.
Dosing
- 1 tablet once daily - preferably at the same time each day
- No dose adjustment needed for mild-moderate renal or hepatic impairment
- Caution in severe hepatic insufficiency
When NOT to Give (Contraindications / Cautions)
- Children under 12 years - avoid
- Known QTc prolongation - ebastine has mild QT effect; use caution with azole antifungals (fluconazole, itraconazole), macrolide antibiotics (erythromycin, clarithromycin), and other QT-prolonging drugs
- Severe liver disease
- Pregnancy - use only if clearly needed (limited data)
Bottom Line
Give Ebast DC in adults and adolescents ≥12 years with allergic rhinitis or chronic urticaria, especially when a single antihistamine alone is not controlling symptoms adequately. It is a once-daily tablet taken orally.
This is a shared conversation. Sign in to Orris to start your own chat.